"Chi-Foon and I have worked successfully as a close-knit team for over a decade to help elevate Synopsys into its present leadership position," said de Geus. "Synopsys has excellent technical, market and financial strengths, as well as a management team capable of scaling the company for continued growth, portfolio broadening and globalization. Explicitly sharing the CEO position is both galvanizing and timely as we now focus on setting the company's direction for the next decade of growth and customer focus."
"I am excited about addressing the opportunities that we see ahead for our company," said Chan. "Synopsys has many talented employees who are dedicated to helping our customers achieve their goals. Building on the entrepreneurial spirit of our management, the execution strength of our worldwide teams, and the healthy technical and economic position of the company, Aart and I look forward to leading the company into its next phase of customer impact and growth."
Chan joined Synopsys in 1990 as vice president of applications and services from NEC Corporation USA, where he was general manager of the microprocessor group. Over the years, he pioneered many aspects of the company including the initiation of Synopsys' IP business. He was appointed president and chief operating officer in 1998, at which time he also joined the Synopsys Board of Directors.
About Synopsys
Synopsys, Inc. (Nasdaq: SNPS) is a world leader in electronic design automation (EDA), supplying the global electronics market with the software, intellectual property (IP) and services used in semiconductor design, verification and manufacturing. Synopsys' comprehensive, integrated portfolio of implementation, verification, IP, manufacturing and field-programmable gate array (FPGA) solutions helps address the key challenges designers and manufacturers face today, such as power and yield management, system-to-silicon verification and time-to-results. These technology-leading solutions help give Synopsys customers a competitive edge in bringing the best products to market quickly while reducing costs and schedule risk. Synopsys is headquartered in Mountain View, California, and has approximately 70 offices located throughout North America, Europe, Japan, Asia and India. Visit Synopsys online at http://www.synopsys.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements related to the continued growth of the company. These statements are based on current expectations and beliefs. Actual results could differ materially from those described by these statements due to risks and uncertainties as detailed in the "Risk Factors" section of Synopsys' Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2012. Synopsys assumes no obligation to update any forward-looking statement contained in this press release.
EDITORIAL CONTACT:
Sheryl Gulizia
Synopsys, Inc.
650-584-8635
Email Contact
INVESTOR CONTACT:
Lisa L. Ewbank
Synopsys, Inc.
650-584-1901
Email Contact
SOURCE Synopsys, Inc.
| Contact: |
| Synopsys, Inc.
Web: http://www.synopsys.com |
